Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History TMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics TMO

Max Ratio

1.22

5Y Dividend Growth

105.00 %

Consecutive Years

7 years

5Y Average Payout Ratio

7.23 %
Forward Annual Dividend Yield 0.40 %
Consecutive Years 7
Forward Annual Dividend 1.72 USD
Consistent Years 13
Dividend CAGR 3Y 14.47 %
Continuous Dividends
Dividend CAGR 5Y 15.47 %
Payout Ratio TTM 7.49 %
Dividend CAGR 10Y 10.03 %
Ex Dividend Date 15.09.2025

Thermo Fisher Scientific Inc

TMO
Current price
434.86 USD +4.61 USD (+1.07%)
Last closed 430.73 USD
ISIN US8835561023
Sector Healthcare
Industry Diagnostics & Research
Exchange NYSE
Capitalization 164 157 046 784 USD
Yield for 12 month -20.16 %
1Y
3Y
5Y
10Y
15Y
TMO
21.11.2021 - 28.11.2021

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Address: 168 Third Avenue, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

554.60 USD

P/E Ratio

25.51

Dividend Yield

0.40 %

Financials TMO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures TMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+42 879 000 000 USD

Last Year

+42 857 000 000 USD

Current Quarter

+10 364 000 000 USD

Last Quarter

+11 395 000 000 USD

Current Year

+17 702 000 000 USD

Last Year

+17 562 000 000 USD

Current Quarter

+4 235 000 000 USD

Last Quarter

+4 925 000 000 USD
EBITDA 10 826 000 384 USD
Operating Margin TTM 17.75 %
Price to Earnings 25.51
Return On Assets TTM 5.00 %
PEG Ratio 1.78
Return On Equity TTM 13.70 %
Wall Street Target Price 554.60 USD
Revenue TTM 42 898 001 920 USD
Book Value 130.84 USD
Revenue Per Share TTM
Dividend Share 1.60 USD
Quarterly Revenue Growth YOY 0.20 %
Dividend Yield 0.40 %
Gross Profit TTM 17 774 999 552 USD
Earnings per share 17.05 USD
Diluted Eps TTM 17.05 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 15.00 %
Profit Margin 15.19 %

Stock Valuation TMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 25.51
Forward PE 19.38
Enterprise Value Revenue 4.49
Price Sales TTM 3.83
Enterprise Value EBITDA 16.91
Price Book MRQ 3.32

Technical Indicators TMO

For 52 Weeks

385.46 USD 625.84 USD
50 Day MA 410.66 USD
Shares Short Prior Month 4 571 597
200 Day MA 503.45 USD
Short Ratio 1.89
Shares Short 4 909 976
Short Percent 1.30 %